Published in Clin Exp Rheumatol on March 14, 2002
Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis (2005) 1.58
Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis (2005) 1.31
Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis (2006) 0.90
Sensitivity and specificity of plain radiographic features of peripheral enthesopathy at major sites in psoriatic arthritis. Skeletal Radiol (2007) 0.85
Assessment of anti-cyclic citrullinated peptide in psoriatic arthritis. BMC Res Notes (2009) 0.82
The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum (1991) 11.66
The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis (2010) 5.24
EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis (2008) 4.88
2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2011) 4.78
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
EULAR recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 3.37
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32
Retrocalcaneal bursitis in spondyloarthropathy: assessment by ultrasonography and magnetic resonance imaging. J Rheumatol (1998) 2.68
Coexistence of ochronosis and ankylosing spondylitis. J Rheumatol (1990) 2.30
EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis (2008) 2.25
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis (2009) 2.22
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Epidemiologic and clinical aspects of Behçet's disease in a defined area of Northwestern Spain, 1988-1997. J Rheumatol (2000) 2.12
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis (1999) 1.97
Takayasu's arteritis: A study of 104 Italian patients. Arthritis Rheum (2005) 1.94
Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum (1998) 1.81
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis. Ann Rheum Dis (2004) 1.76
Psoriatic arthritis. Curr Opin Rheumatol (1998) 1.69
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug. Arthritis Rheum (2001) 1.68
Genetic markers and quantitative genetic variation in Medicago truncatula (Leguminosae): a comparative analysis of population structure. Genetics (1996) 1.65
Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis (2008) 1.65
Divergent evolution of dispersal in a heterogeneous landscape. Evolution (2001) 1.63
Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis. Br J Rheumatol (1993) 1.52
Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) (2008) 1.52
Comparative allozyme and microsatellite population structure in a narrow endemic plant species, Centaurea corymbosa Pourret (Asteraceae). Mol Ecol (2001) 1.51
Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study. J Rheumatol (2000) 1.48
Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging. Ann Rheum Dis (1998) 1.44
Polymyalgia rheumatica: a disorder of extraarticular synovial structures? J Rheumatol (1999) 1.44
Centaurea corymbosa, a cliff-dwelling species tottering on the brink of extinction: a demographic and genetic study. Proc Natl Acad Sci U S A (1997) 1.35
Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica. Arthritis Rheum (1997) 1.33
Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease. Ann Rheum Dis (2008) 1.32
RS3PE syndrome: an overview. Clin Exp Rheumatol (2000) 1.32
The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol (2000) 1.30
Treatment of longstanding active giant cell arteritis with infliximab: report of four cases. Arthritis Rheum (2001) 1.27
Inbreeding depression in small populations of self-incompatible plants. Genetics (2001) 1.27
Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol (2001) 1.24
Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Clin Exp Rheumatol (2000) 1.24
Behçet's disease and cardiovascular involvement. Lupus (2005) 1.23
Genetic diversity and population structure of an insular tree, Santalum austrocaledonicum in New Caledonian archipelago. Mol Ecol (2005) 1.20
Evolution of reproductive effort in a metapopulation with local extinctions and ecological succession. Am Nat (1997) 1.19
Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol (2005) 1.16
Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum (2000) 1.15
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) (2008) 1.13
Successful treatment of SAPHO syndrome with infliximab: report of two cases. Ann Rheum Dis (2002) 1.13
Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int (2000) 1.13
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis. Ann Rheum Dis (2006) 1.12
The psoriatic arthritis cost evaluation study: a cost-of-illness study on tumour necrosis factor inhibitors in psoriatic arthritis patients with inadequate response to conventional therapy. Rheumatology (Oxford) (2008) 1.12
Classification of inflammatory arthritis. Lancet (1998) 1.07
Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med (1997) 1.07
Vascular endothelial growth factor production in polymyalgia rheumatica. Arthritis Rheum (2000) 1.06
Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study. Rheumatology (Oxford) (2007) 1.06
Fine-scale genetic structure and gene dispersal in Centaurea corymbosa (Asteraceae) I. Pattern of pollen dispersal. J Evol Biol (2004) 1.05
Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol (2001) 1.04
Permanent Genetic Resources added to Molecular Ecology Resources database 1 January 2009-30 April 2009. Mol Ecol Resour (2009) 1.04
HCV infection: pathogenesis, clinical manifestations and therapy. Clin Exp Rheumatol (2008) 1.03
Adaptation in a spider mite population after long-term evolution on a single host plant. J Evol Biol (2007) 1.03
Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases? J Rheumatol (1997) 1.02
An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis. Ann Rheum Dis (2006) 1.02
Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate. Clin Exp Rheumatol (1999) 0.98
Psoriasis and psoriatic arthritis: immunological aspects and therapeutic guidelines. Clin Exp Rheumatol (2006) 0.98
Relationship between plasma profiles of oxytocin and adrenocorticotropic hormone during suckling or breast stimulation in women. Horm Res (1991) 0.97
Conjunctival ulceration in Behçet's syndrome. Ann Rheum Dis (1992) 0.96
Diffuse idiopathic skeletal hyperostosis may give the typical postural abnormalities of advanced ankylosing spondylitis. Rheumatology (Oxford) (2007) 0.96
Ankylosing spondylitis and undifferentiated spondyloarthropathies: a clinical review and description of a disease subset with older age at onset. Curr Opin Rheumatol (2001) 0.96
Spatial effects and rare outcrossing events in Medicago truncatula (Fabaceae). Mol Ecol (2001) 0.95
Medicago-Sinorhizobium symbiotic specificity evolution and the geographic expansion of Medicago. J Evol Biol (2005) 0.95
The causes of uveitis in a referral centre of Northern Italy. Int Ophthalmol (2010) 0.94
Dissemination and evaluation of the ASAS/EULAR recommendations for the management of ankylosing spondylitis: results of a study among 1507 rheumatologists. Ann Rheum Dis (2007) 0.94
Aortic involvement in ankylosing spondylitis. Clin Exp Rheumatol (2008) 0.94
Effective population size associated with self-fertilization: lessons from temporal changes in allele frequencies in the selfing annual Medicago truncatula. J Evol Biol (2007) 0.94
Urticaria/arthritis syndrome: report of four B51 positive patients. Ann Rheum Dis (1989) 0.94
Entheseal involvement. Clin Exp Rheumatol (2009) 0.94
A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol (2001) 0.93
Seronegative spondylarthropathies: imaging of spondylitis, enthesitis and dactylitis. Eur J Radiol (1998) 0.92
Density and genetic relatedness increase dispersal distance in a subsocial organism. Ecol Lett (2013) 0.92
Muscoloskeletal manifestations in inflammatory bowel disease. Can J Gastroenterol (2001) 0.91
Treating axial and peripheral spondyloarthritis, including psoriatic arthritis, to target: results of a systematic literature search to support an international treat-to-target recommendation in spondyloarthritis. Ann Rheum Dis (2013) 0.91
Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum (1996) 0.91
Molecular phylogenetic approach for studying life-history evolution: the ambiguous example of the genus Medicago L. Proc Biol Sci (1998) 0.91
EMG, bite force, and elongation of the masseter muscle under isometric voluntary contractions and variations of vertical dimension. J Prosthet Dent (1979) 0.91
Frequency and duration of clinical remission in patients with peripheral psoriatic arthritis requiring second-line drugs. Rheumatology (Oxford) (2008) 0.91
Isolation and characterization of microsatellites in the endemic species Centaurea corymbosa Pourret (Asteraceae) and other related species. Mol Ecol (2000) 0.90